Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas

Langenes, Veronica ; Svensson, Helena ; Börjesson, Lars ; Gustavsson, Bengt ; Bemark, Mats LU orcid ; Sjöling, Åsa and Quiding-Järbrink, Marianne (2013) In Cancer Immunology, Immunotherapy 62(11). p.1687-1695
Abstract

Recruitment of immune cells to tumors is a complex process crucial for both inflammation-driven tumor progression and specific anti-tumor cytotoxicity. Chemokines control the directed migration of immune cells, and their actions are partly controlled by nonsignaling chemokine decoy receptors. The role of the receptors such as D6, Duffy antigen receptor for chemokines and ChemoCentryx chemokine receptor in immunity to tumors is still unclear. Using real-time PCR, we detected significantly decreased expression of D6 mRNA in colon tumors compared to unaffected mucosa. D6 protein was expressed by lymphatic endothelium and mononuclear cells in the colon lamina propria and detected by immunohistochemistry in two out of six tissue samples... (More)

Recruitment of immune cells to tumors is a complex process crucial for both inflammation-driven tumor progression and specific anti-tumor cytotoxicity. Chemokines control the directed migration of immune cells, and their actions are partly controlled by nonsignaling chemokine decoy receptors. The role of the receptors such as D6, Duffy antigen receptor for chemokines and ChemoCentryx chemokine receptor in immunity to tumors is still unclear. Using real-time PCR, we detected significantly decreased expression of D6 mRNA in colon tumors compared to unaffected mucosa. D6 protein was expressed by lymphatic endothelium and mononuclear cells in the colon lamina propria and detected by immunohistochemistry in two out of six tissue samples containing high D6 mRNA levels, whereas no staining was observed in any tissue samples expressing low mRNA levels. When examining the density of lymphatic vessels in colon tumors, we detected a marked increase in vessels identified by the lymphatic endothelial marker Lyve-1, excluding passive regulation of D6 due to decreased lymphatic vessel density. In parallel, the Treg-recruiting chemokine CCL22, which is sequestered by D6, was threefold increased in tumor tissue. Furthermore, we could show that low D6 expression correlated to more invasive tumors and that tumor location influences D6 expression, which is lower in the more distal parts of the colon. The data support that regulation of D6 by colon tumors results in altered levels of proinflammatory CC chemokines, thereby shaping the local chemokine network to favor tumor survival. This may have implications for the design of future immunotherapy for colon cancer.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
publishing date
type
Contribution to journal
publication status
published
keywords
CCX-CKR, Chemokine receptor, Colon adenocarcinoma, D6, DARC
in
Cancer Immunology, Immunotherapy
volume
62
issue
11
pages
1687 - 1695
publisher
Springer
external identifiers
  • pmid:24013383
  • scopus:84888323055
ISSN
0340-7004
DOI
10.1007/s00262-013-1472-0
language
English
LU publication?
no
additional info
.
id
9ca65770-58a2-4950-876c-b93cf770e6de
date added to LUP
2023-12-06 16:43:51
date last changed
2024-04-19 11:19:50
@article{9ca65770-58a2-4950-876c-b93cf770e6de,
  abstract     = {{<p>Recruitment of immune cells to tumors is a complex process crucial for both inflammation-driven tumor progression and specific anti-tumor cytotoxicity. Chemokines control the directed migration of immune cells, and their actions are partly controlled by nonsignaling chemokine decoy receptors. The role of the receptors such as D6, Duffy antigen receptor for chemokines and ChemoCentryx chemokine receptor in immunity to tumors is still unclear. Using real-time PCR, we detected significantly decreased expression of D6 mRNA in colon tumors compared to unaffected mucosa. D6 protein was expressed by lymphatic endothelium and mononuclear cells in the colon lamina propria and detected by immunohistochemistry in two out of six tissue samples containing high D6 mRNA levels, whereas no staining was observed in any tissue samples expressing low mRNA levels. When examining the density of lymphatic vessels in colon tumors, we detected a marked increase in vessels identified by the lymphatic endothelial marker Lyve-1, excluding passive regulation of D6 due to decreased lymphatic vessel density. In parallel, the Treg-recruiting chemokine CCL22, which is sequestered by D6, was threefold increased in tumor tissue. Furthermore, we could show that low D6 expression correlated to more invasive tumors and that tumor location influences D6 expression, which is lower in the more distal parts of the colon. The data support that regulation of D6 by colon tumors results in altered levels of proinflammatory CC chemokines, thereby shaping the local chemokine network to favor tumor survival. This may have implications for the design of future immunotherapy for colon cancer.</p>}},
  author       = {{Langenes, Veronica and Svensson, Helena and Börjesson, Lars and Gustavsson, Bengt and Bemark, Mats and Sjöling, Åsa and Quiding-Järbrink, Marianne}},
  issn         = {{0340-7004}},
  keywords     = {{CCX-CKR; Chemokine receptor; Colon adenocarcinoma; D6; DARC}},
  language     = {{eng}},
  number       = {{11}},
  pages        = {{1687--1695}},
  publisher    = {{Springer}},
  series       = {{Cancer Immunology, Immunotherapy}},
  title        = {{Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas}},
  url          = {{http://dx.doi.org/10.1007/s00262-013-1472-0}},
  doi          = {{10.1007/s00262-013-1472-0}},
  volume       = {{62}},
  year         = {{2013}},
}